NEW BRUNSWICK, N.J., June 12 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT) today announced that the Company will be presenting at the Business Forum during BIO 2008, the Biotechnology Industry Organization's Annual International Convention, which is being held at the San Diego Convention Center from June 17-20, 2008. Bruce Galton, Chief Executive Officer of Senesco, will deliver the Company's corporate presentation on Wednesday, June 18th, at 3:30 p.m. local time in Room 2.
The BIO Business Forum is the largest partnering and networking program in the industry. It offers pharmaceutical and biotechnology companies, academic research institutions and investors from around the world the unique opportunity to gather in one place at one time to learn about each other and meet one-on-one to discuss business opportunities of mutual interest.
About Senesco Technologies, Inc.
Senesco has initiated preclinical research to trigger or delay cell
death in mammals (apoptosis) to determine if its technology is applicable
in human medicine. Accelerating apoptosis may have applications to the
development of cancer treatments. Delaying apoptosis may have applications
to certain diseases such as glaucoma, ischemia and arthritis, among others.
Senesco takes its name from the scientific term for the aging of plant
cells: senescence. The Company has developed technology that regulates the
onset of cell death. Delaying cell breakdown in plants extends freshness
after harvesting, while increasing crop yields, plant size and resistance
to environmental stress for flowers, fruits and vegetables. In addition to
its human health research programs, the Company believes that its
technology can be used
|SOURCE Senesco Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved